Lapatinib plus capecitabine for brain metastases in patients with human epidermal growth factor receptor 2-positive advanced breast cancer: a review of the Anatolian Society of Medical Oncology (ASMO) experience.
about
Lapatinib plus Capecitabine for HER2-Positive Advanced-Stage Breast Cancer in Elderly Women: Review of the Anatolian Society of Medical Oncology (ASMO) Experience.Exploration and validation of radiomics signature as an independent prognostic biomarker in stage III-IVb nasopharyngeal carcinoma.Systemic Treatment Options for HER2-Positive Breast Cancer Patients with Brain Metastases beyond Trastuzumab: A Literature Review.Lapatinib plus capecitabine for HER2-positive advanced breast cancer: a multicentre study of Anatolian Society of Medical Oncology (ASMO).
P2860
Lapatinib plus capecitabine for brain metastases in patients with human epidermal growth factor receptor 2-positive advanced breast cancer: a review of the Anatolian Society of Medical Oncology (ASMO) experience.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Lapatinib plus capecitabine fo ...... al Oncology (ASMO) experience.
@en
type
label
Lapatinib plus capecitabine fo ...... al Oncology (ASMO) experience.
@en
prefLabel
Lapatinib plus capecitabine fo ...... al Oncology (ASMO) experience.
@en
P2093
P2860
P356
P1433
P1476
Lapatinib plus capecitabine fo ...... cal Oncology (ASMO) experience
@en
P2093
Abdurrahman Isıkdogan
Alper Sevinc
Arife Ulas
Berna Oksuzoglu
Bulent Cetin
Burcak Yilmaz
Cem Boruban
Dogan Koca
Dogan Uncu
Faysal Dane
P2860
P304
P356
10.1159/000345040
P577
2012-10-31T00:00:00Z